Cultural, racial and socioeconomic barriers play a role in barriers to access, from cultural hesitancy around seeking care to distrust of healthcare institutions to the stigmatizing of Medicaid beneficiaries. As a result, engaging these populations is highly complex, highly nuanced work.
A better coronary artery stent cannot help a patient who cannot afford it, does not know they need it, doesn’t have a doctor who can make a diagnosis and identify that need. To help these patients, we urgently need to look at health equity.
In an era of escalating healthcare costs and a growing preference for natural, holistic approaches to health, The Impact Brands emerges as a collective of diverse brands dedicated to supporting overall wellness through natural means.
With proactive outreach by highly trained community health navigators guided by data and leveraging easy-to-use technology, we could get ahead of an individual’s needs, design and execute a care plan, and – hopefully – keep them out of the hospital.
More health care providers are seeing patients on an outpatient basis, but simply getting to a doctor visit can be a formidable obstacle for those managing physical and developmental disabilities.
The pandemic changed ideas and helped create new solutions to improve how and where patients access care whether it be through a smartphone-based transportation app with healthy meal delivery or remote patient monitoring.
Despite all the impassioned calls to action and carefully-considered strategies — and the undeniable conviction behind both — the same question kept lingering in the back of my mind: “Haven’t I heard this before?” Still, I remain hopeful.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
MedCity News is once again partnering with the New Orleans Business Alliance to host the executive summit INVEST Pop Health Virtual.
SDoH is just one of the topics at the MedCity INVEST Digital Health conference, a virtual event scheduled for September 20-23, in collaboration with Medical Alley.
Covid-19 has demonstrated the grave need for us to invest in chronic disease prevention and support by building stronger, deeper relationships with patients and families, and by focusing more on the environmental, social, and psychological factors that lead to chronic disease and impact long-term disease management.
As a country, we must do a better job supporting people and communities throughout their health journey because communities with greater access to information and increased levels of health literacy will ensure better health outcomes.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
There should be a discussion about how to address the disproportionate impact Covid-19 has had on Black communities.
To reduce the systemic health inequities that have put so many individuals at higher risk of getting sick and dying from Covid-19, healthcare organizations must leverage advanced technologies such as NLP to identify SDoH and other critical information from unstructured notes.
Paying close attention to social determinants of health, like ability to drive or proximity to a grocery store, can also help predict who is at highest risk of being food insecure which, in turn, can help a plan know which resources to offer to those members.
The healthcare startups targeting chronic conditions and population health presenting at INVEST Pop Health November 16-18 span prescription drug delivery to addressing social isolation.
With the annual INVEST Population Health virtual conference coming up November 16-18, here's a look at our collaboration partner New Orleans Business Alliance. It plays a vital role in helping to stimulate the local economy by supporting the development and advancement of the healthcare and biotech infrastructure.